Works matching AU Hiroshi Shibata

Results: 136
    1
    2
    3

    Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.

    Published in:
    Gastroenterology Report, 2021, v. 9, n. 2, p. 133, doi. 10.1093/gastro/goaa042
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Ogawa, Chikara;
    • Tani, Joji;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Kawata, Kazuhito;
    • Toyoda, Hidenori;
    • Ohama, Hideko
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96089-x
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Tani, Joji;
    • Kariyama, Kazuya;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Kawata, Kazuhito;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Aoki, Tomoko
    Publication type:
    Article
    13

    Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93794-5
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Fukunishi, Shinya;
    • Ohama, Hideko;
    • Kawata, Kazuhito;
    • Tani, Joji
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Cellsorba.

    Published in:
    Therapeutic Apheresis & Dialysis, 2003, v. 7, n. 1, p. 44, doi. 10.1046/j.1526-0968.2003.00009.x
    By:
    • Shibata, Hiroshi;
    • Kuriyama, Toshiji;
    • Yamawaki, Naokuni
    Publication type:
    Article
    23
    24
    25
    26

    Antihypertensive Effect of Angiotensin I-Converting Enzyme Inhibitory Peptides from a Sesame Protein Hydrolysate in Spontaneously Hypertensive Rats.

    Published in:
    Bioscience, Biotechnology & Biochemistry, 2006, v. 70, n. 5, p. 1118, doi. 10.1271/bbb.70.1118
    By:
    • Nakano, Daisuke;
    • Ogura, Kyoichi;
    • Miyakoshi, Masazurni;
    • Ishii, Fumie;
    • Kawanishi, Hideaki;
    • Kurumazuka, Daisuke;
    • Kwak, Chol-jun;
    • Ikemura, Kenji;
    • Takaoka, Masanori;
    • Moriguchi, Shigeo;
    • Iino, Taeko;
    • Kusumoto, Aki;
    • Asami, Sumio;
    • Shibata, Hiroshi;
    • Kiso, Yoshinobu;
    • Matsumura, Yasuo
    Publication type:
    Article
    27
    28

    Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.

    Published in:
    Oncology, 2022, v. 100, n. 2, p. 65, doi. 10.1159/000520292
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Kariyama, Kazuya;
    • Toyoda, Hidenori;
    • Yasuda, Satoshi;
    • Tsuji, Kunihiko;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Naganuma, Atsushi;
    • Ishikawa, Toru;
    • Tada, Toshifumi;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Tanaka, Takaaki;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Imai, Michitaka;
    • Nakamura, Shinichiro
    Publication type:
    Article
    29

    Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

    Published in:
    Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Michitaka, Kojiro;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Fukunishi, Shinya;
    • Ohama, Hideko;
    • Kawata, Kazuhito
    Publication type:
    Article
    30

    Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Kawata, Kazuhito;
    • Toyoda, Hidenori;
    • Ohama, Hideko;
    • Tsutsui, Akemi;
    • Itokawa, Norio
    Publication type:
    Article
    31

    Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Itokawa, Norio;
    • Hayama, Korenobu
    Publication type:
    Article
    32

    Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Itokawa, Norio;
    • Hayama, Korenobu
    Publication type:
    Article
    33

    Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2023, v. 53, n. 2, p. 172, doi. 10.1111/hepr.13845
    By:
    • Tomonari, Tetsu;
    • Tani, Joji;
    • Ogawa, Chikara;
    • Deguchi, Akihiro;
    • Senoh, Tomonori;
    • Moriya, Akio;
    • Shibata, Hiroshi;
    • Fukuno, Hiroshi;
    • Tanaka, Hironori;
    • Tanaka, Takahiro;
    • Taniguchi, Tatsuya;
    • Sogabe, Masahiro;
    • Kawano, Yutaka;
    • Morishita, Akihiro;
    • Takaguchi, Koichi;
    • Miyamoto, Hiroshi;
    • Sato, Yasushi;
    • Masaki, Tsutomu;
    • Takayama, Tetsuji
    Publication type:
    Article
    34

    Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.

    Published in:
    Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Hatanaka, Takeshi;
    • Tada, Toshifumi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Kawata, Kazuhito;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori
    Publication type:
    Article
    35

    Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.

    Published in:
    Hepatology Research, 2021, v. 51, n. 2, p. 201, doi. 10.1111/hepr.13592
    By:
    • Chuma, Makoto;
    • Uojima, Haruki;
    • Hiraoka, Atsushi;
    • Kobayashi, Satoshi;
    • Toyoda, Hidenori;
    • Tada, Toshifumi;
    • Hidaka, Hisashi;
    • Iwabuchi, Shogo;
    • Numata, Kazushi;
    • Itobayashi, Ei;
    • Itokawa, Norio;
    • Kariyama, Kazuya;
    • Ohama, Hideko;
    • Hattori, Nobuhiro;
    • Hirose, Shunji;
    • Shibata, Hiroshi;
    • Tani, Joji;
    • Imai, Michitaka;
    • Tajiri, Kazuto;
    • Moriya, Satoshi
    Publication type:
    Article
    36
    37

    Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.

    Published in:
    Hepatology Research, 2020, v. 50, n. 1, p. 75, doi. 10.1111/hepr.13427
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Michitaka, Kojiro;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Itokawa, Norio
    Publication type:
    Article
    38

    Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 1, p. 111, doi. 10.1111/hepr.13243
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Kariyama, Kazuya;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Shimada, Noritomo;
    • Tajiri, Kazuto;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Ochi, Hironori;
    • Hirooka, Masashi;
    • Tsutsui, Akemi;
    • Shibata, Hiroshi;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Joko, Kouji;
    • Hiasa, Yoichi;
    • Michitaka, Kojiro
    Publication type:
    Article
    39

    Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients.

    Published in:
    Hepatology Research, 2012, v. 42, n. 11, p. 1058, doi. 10.1111/j.1872-034X.2012.01025.x
    By:
    • Koda, Masahiko;
    • Murawaki, Yoshikazu;
    • Hirooka, Yasuaki;
    • Kitamoto, Mikiya;
    • Ono, Masafumi;
    • Sakaeda, Hiroshi;
    • Joko, Kouji;
    • Sato, Shuichi;
    • Tamaki, Katsuyoshi;
    • Yamasaki, Takahiro;
    • Shibata, Hiroshi;
    • Shimoe, Toshinari;
    • Matsuda, Tadakazu;
    • Toshikuni, Nobuyuki;
    • Fujioka, Shin-ichi;
    • Ohmoto, Kenji;
    • Nakamura, Shinichiro;
    • Kariyama, Kazuya;
    • Aikata, Hiroshi;
    • Kobayashi, Yoshiyuki
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50